Literature DB >> 18566511

High-resolution structure of unbound human immunodeficiency virus 1 subtype C protease: implications of flap dynamics and drug resistance.

Roxana M Coman1, Arthur H Robbins, Maureen M Goodenow, Ben M Dunn, Robert McKenna.   

Abstract

The X-ray crystal structure of the unbound state of human immunodeficiency virus 1 (HIV-1) subtype C protease (C PR) has been determined to 1.20 angstroms resolution in the tetragonal space group P4(1)2(1)2, with one monomer per asymmetric unit and unit-cell parameters a = 46.7, c = 100.8 angstroms, allowing full anisotropic least-squares refinement. The refined model has a conventional R factor of 14.1% for all reflections and estimated standard deviations in bond lengths and angles for all main-chain non-H atoms of 0.014 angstroms and 0.030 degrees , respectively. The structure is compared with three unbound subtype B proteases (B PRs) to identify structural changes arising from the naturally occurring polymorphisms and delineate their implications in antiretroviral drug resistance/susceptibility. The unbound C PR exhibits a larger distance between the tips of the flaps, a downward displacement of the 36-41 loop and an increased thermal stability of the 10s loop when compared with the B PR structures. The C PR structure presents the highest resolution of the unbound state of a non-subtype-B PR and adds to the understanding of flap dynamics and drug resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566511     DOI: 10.1107/S090744490801278X

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  9 in total

1.  Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.

Authors:  Zhanglong Liu; Thomas M Casey; Mandy E Blackburn; Xi Huang; Linh Pham; Ian Mitchelle S de Vera; Jeffrey D Carter; Jamie L Kear-Scott; Angelo M Veloro; Luis Galiano; Gail E Fanucci
Journal:  Phys Chem Chem Phys       Date:  2016-02-17       Impact factor: 3.676

2.  F99 is critical for dimerization and activation of South African HIV-1 subtype C protease.

Authors:  Previn Naicker; Palesa Seele; Heini W Dirr; Yasien Sayed
Journal:  Protein J       Date:  2013-10       Impact factor: 2.371

3.  Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes.

Authors:  Arthur H Robbins; Roxana M Coman; Edith Bracho-Sanchez; Marty A Fernandez; C Taylor Gilliland; Mi Li; Mavis Agbandje-McKenna; Alexander Wlodawer; Ben M Dunn; Robert McKenna
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-02-12

4.  Inhibitor-induced conformational shifts and ligand-exchange dynamics for HIV-1 protease measured by pulsed EPR and NMR spectroscopy.

Authors:  Xi Huang; Ian Mitchelle S de Vera; Angelo M Veloro; Mandy E Blackburn; Jamie L Kear; Jeffery D Carter; James R Rocca; Carlos Simmerling; Ben M Dunn; Gail E Fanucci
Journal:  J Phys Chem B       Date:  2012-11-30       Impact factor: 2.991

5.  Design of substituted bis-Tetrahydrofuran (bis-THF)-derived Potent HIV-1 Protease Inhibitors, Protein-ligand X-ray Structure, and Convenient Syntheses of bis-THF and Substituted bis-THF Ligands.

Authors:  Arun K Ghosh; Cuthbert D Martyr; Melinda Steffey; Yuan-Fang Wang; Johnson Agniswamy; Masayuki Amano; Irene T Weber; Hiroaki Mitsuya
Journal:  ACS Med Chem Lett       Date:  2011-04-14       Impact factor: 4.345

6.  Substituted Bis-THF Protease Inhibitors with Improved Potency against Highly Resistant Mature HIV-1 Protease PR20.

Authors:  Johnson Agniswamy; John M Louis; Chen-Hsiang Shen; Sofiya Yashchuk; Arun K Ghosh; Irene T Weber
Journal:  J Med Chem       Date:  2015-06-04       Impact factor: 7.446

7.  Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility.

Authors:  Jamie L Kear; Mandy E Blackburn; Angelo M Veloro; Ben M Dunn; Gail E Fanucci
Journal:  J Am Chem Soc       Date:  2009-10-21       Impact factor: 15.419

8.  Overexpression, Purification and Functional Characterisation of Wild-Type HIV-1 Subtype C Protease and Two Variants Using a Thioredoxin and His-Tag Protein Fusion System.

Authors:  Jake Zondagh; Alison Williams; Ikechukwu Achilonu; Heini W Dirr; Yasien Sayed
Journal:  Protein J       Date:  2018-08       Impact factor: 2.371

9.  Genetic Diversity and Low Therapeutic Impact of Variant-Specific Markers in HIV-1 Pol Proteins.

Authors:  Paloma Troyano-Hernáez; Roberto Reinosa; Africa Holguín
Journal:  Front Microbiol       Date:  2022-07-14       Impact factor: 6.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.